Sign inGet started

Amello Jason

Insider CIK 1451805 · ACER Director · ZIOP Executive Vice President & CFO · AKBA SVP, CFO & Treasurer · TCRX Chief Financial Officer · CADL Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TCRX TScan Therapeutics, Inc. A Award deriv2026-01-202026-01-22350,000— $0350,000SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2025-01-032025-02-11270,000— $0270,000SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2024-02-012024-02-02750,000— $0750,000SEC↗
CADL Candel Therapeutics, Inc. F Tax w/h2023-11-282023-11-3020,153$0.90 $18.1K202,009SEC↗
CADL Candel Therapeutics, Inc. A Award2023-11-262023-11-28125,717— $0222,162SEC↗
CADL Candel Therapeutics, Inc. A Award deriv2023-04-282023-05-0290,000— $090,000SEC↗
ACER Acer Therapeutics Inc. A Award deriv2023-03-142023-03-1620,000— $020,000SEC↗
CADL Candel Therapeutics, Inc. P Buy2022-12-092022-12-122,468$1.93 $4.8K5,568SEC↗
CADL Candel Therapeutics, Inc. P Buy2022-12-082022-12-123,100$1.69 $5.2K3,100SEC↗
CADL Candel Therapeutics, Inc. A Award2022-11-282022-11-3090,877— $090,877SEC↗
CADL Candel Therapeutics, Inc. A Award deriv2022-09-212022-09-23230,000— $0230,000SEC↗
ACER Acer Therapeutics Inc. A Award deriv2022-01-142022-01-1918,500— $018,500SEC↗
ACER Acer Therapeutics Inc. A Award deriv2021-01-152021-01-2015,000— $015,000SEC↗
AKBA Akebia Therapeutics, Inc. A Award deriv2020-02-282020-03-0245,000— $045,000SEC↗
AKBA Akebia Therapeutics, Inc. S Sale2020-02-282020-03-026,976$8.70 $60.7K144,642SEC↗
AKBA Akebia Therapeutics, Inc. A Award2020-02-282020-03-0230,000— $0151,618SEC↗
ACER Acer Therapeutics Inc. A Award deriv2020-01-022020-01-039,000— $09,000SEC↗
AKBA Akebia Therapeutics, Inc. D To issuer2019-04-112019-04-1213,148$7.70 $101.2K118,618SEC↗
AKBA Akebia Therapeutics, Inc. A Award deriv2019-02-282019-03-05100,000— $0100,000SEC↗
AKBA Akebia Therapeutics, Inc. A Award2019-02-282019-03-0565,000— $0131,766SEC↗
ACER Acer Therapeutics Inc. A Award deriv2019-02-012019-02-056,000— $06,000SEC↗
AKBA Akebia Therapeutics, Inc. F Tax w/h2018-12-122018-12-1322,235$8.94 $198.8K66,501SEC↗
AKBA Akebia Therapeutics, Inc. A Award deriv2018-02-282018-03-0227,700— $027,700SEC↗
AKBA Akebia Therapeutics, Inc. A Award2018-02-282018-03-0219,500— $087,236SEC↗
ACER Acer Therapeutics Inc. A Award deriv2017-10-042017-10-069,000— $09,000SEC↗
AKBA Akebia Therapeutics, Inc. A Award deriv2017-02-212017-02-2347,500$10.14 $481.6K47,500SEC↗
AKBA Akebia Therapeutics, Inc. A Award2017-02-212017-02-2330,000— $065,637SEC↗
AKBA Akebia Therapeutics, Inc. A Award deriv2016-02-222016-02-2439,650— $039,650SEC↗
AKBA Akebia Therapeutics, Inc. A Award2016-02-222016-02-2426,000— $033,330SEC↗
AKBA Akebia Therapeutics, Inc. A Award deriv2015-03-062015-03-1045,000— $045,000SEC↗
AKBA Akebia Therapeutics, Inc. P Buy2014-11-262014-12-011,000$13.22 $13.2K5,000SEC↗
AKBA Akebia Therapeutics, Inc. A Award deriv2014-05-142014-08-0521,667— $021,667SEC↗
AKBA Akebia Therapeutics, Inc. P Buy2014-03-252014-03-274,000$17.00 $68.0K4,000SEC↗
ZIOP ZIOPHARM ONCOLOGY INC F Tax w/h2013-05-082013-05-142,623$1.65 $4.3K22,377SEC↗
ZIOP ZIOPHARM ONCOLOGY INC A Award deriv2012-12-312013-01-03150,000— $0150,000SEC↗
ZIOP ZIOPHARM ONCOLOGY INC A Award deriv2012-06-202012-06-22200,000— $0200,000SEC↗
ZIOP ZIOPHARM ONCOLOGY INC A Award2012-05-082012-05-1025,000— $025,000SEC↗